About Allogene (ALLO)
Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogene... Read more
- USD2.99
- USD3.05
- USD2.86
- USD5.78
- 21.30%
- 0M
- 1.60M
- 2.88M
- 590M
- 2.01
- -42.00%
Stock News
6 hours ago
1 Wall Street Analyst Thinks Tesla Stock Is Going to $258. Is It a Buy After a Post-Earnings Pullback?
Yahoo
7 hours ago
Warren Buffett Is in a Selling Mood. What’s Next?
Yahoo
7 hours ago
Weekly Market Outlook: Central Banks And U.S. Earnings. Will The BoJ Hike Rates?
SeekingAlpha
yesterday
Ackman’s Pershing Square USA says IPO is still happening, despite NYSE delay notice
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
